| Dr. Michael Horne - Chief Scientific Officer Michael Horne is an internationally regarded scientist who has led numerous scientific teams in the successful development and production of commercial human and animal healthcare products. Dr. Horne has demonstrated expertise in micro-organism product development in the commercial business sector. Most recently, he held the position of Director of Research in the animal health division of Novartis AG. While at Novartis, he played a leading role in the expansion of the company's aquaculture franchise, including the development of the world's first commercialized, fully licensed DNA vaccine. He is the author of more than 100 technical, scientific and general publications, and participates on numerous international scientific committees. As the company's chief scientific officer, Dr. Horne will devote himself full-time to leading and mentoring Functional Technologies' growing research and development team; supporting the commercial development and rollout of the company's proprietary Phyterra-branded yeast and micro algae-derived products; and expanding the company's product pipeline through the development of new and next-generation products and technologies identified as having commercial market applications in the functional foods and health products markets. He will be based in the United Kingdom in order to provide the company with key visibility in the important European market, and to help facilitate Functional Technologies' future expansion into Europe. |